Study S001815

Pre-approval Expanded Access of Retatrutide (LY3437943)

Name: LivingGLP1 adjudicated trial data and network meta-analysis results
Creator: Ahmad Sofi-Mahmudi
License: https://creativecommons.org/licenses/by/4.0/

ClinicalTrials.gov record

Registration

Registration: NCT07629401
Study type: EXPANDED_ACCESS
Status: AVAILABLE
Lead sponsor: Eli Lilly and Company
Conditions: Obesity; Obesity-related Complications
Interventions: DRUG:Retatrutide
Results posted: FALSE
Secondary identifiers: REGISTRY:J1I-MC-Y001

Registered primary outcomes

None registered.

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.